Skip to main content

Coronavirus (COVID-19): Visitor Restrictions, Resources, and Updates

Explore URMC
menu
URMC / Research / Clinical Trials / Study Details

Convalescent Plasma to Limit SARS-CoV-2 Associated Complications (CSSC-004)

Research Question:
Does convalescent plasma help treat participants who are COVID-19 positive?

Basic Study Information

Purpose:
The purpose of this study is to is to determine if convalescent plasma will help in reducing hospitalization and death in participants with a postive COVID-19 test and have developed symptoms of COVID-19. COVID-19 symptoms include but are not limited to fever, cough, or loss of test or smell. You must be 18 years or older to participate.

Location: Clinical Research Center
Study Reference #: 4965

Lead Researcher (Principal Investigator)

Lead Researcher:  Martin Zand

Study Contact Information

Study Coordinator: Susanne Heininger
Phone: (585) 273-1926
Email: Susanne_Heininger@URMC.Rochester.edu

Additional Study Details

Number of Visits:  2 to 5
Parking:  Free
Transportation Coverage:  No
Reimbursement:  Yes

Contact This Study

This field is required
This field is required
You must agree to be contacted to continue.

Return to Search